BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24833109)

  • 1. Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior.
    Grindel BJ; Martinez JR; Pennington CL; Muldoon M; Stave J; Chung LW; Farach-Carson MC
    Matrix Biol; 2014 Jun; 36():64-76. PubMed ID: 24833109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrilysin/MMP-7 Cleavage of Perlecan/HSPG2 Complexed with Semaphorin 3A Supports FAK-Mediated Stromal Invasion by Prostate Cancer Cells.
    Grindel BJ; Martinez JR; Tellman TV; Harrington DA; Zafar H; Nakhleh L; Chung LW; Farach-Carson MC
    Sci Rep; 2018 May; 8(1):7262. PubMed ID: 29740048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients.
    Grindel B; Li Q; Arnold R; Petros J; Zayzafoon M; Muldoon M; Stave J; Chung LW; Farach-Carson MC
    Oncotarget; 2016 Mar; 7(9):10433-47. PubMed ID: 26862737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleavage of the Perlecan-Semaphorin 3A-Plexin A1-Neuropilin-1 (PSPN) Complex by Matrix Metalloproteinase 7/Matrilysin Triggers Prostate Cancer Cell Dyscohesion and Migration.
    Tellman TV; Cruz LA; Grindel BJ; Farach-Carson MC
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activation by NFκB increases perlecan/HSPG2 expression in the desmoplastic prostate tumor microenvironment.
    Warren CR; Grindel BJ; Francis L; Carson DD; Farach-Carson MC
    J Cell Biochem; 2014 Jul; 115(7):1322-33. PubMed ID: 24700612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flipping the Molecular Switch: Influence of Perlecan and Its Modifiers in the Tumor Microenvironment.
    Cruz LA; Tellman TV; Farach-Carson MC
    Adv Exp Med Biol; 2020; 1245():133-146. PubMed ID: 32266656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders.
    Farach-Carson MC; Warren CR; Harrington DA; Carson DD
    Matrix Biol; 2014 Feb; 34():64-79. PubMed ID: 24001398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation.
    Ishijima M; Suzuki N; Hozumi K; Matsunobu T; Kosaki K; Kaneko H; Hassell JR; Arikawa-Hirasawa E; Yamada Y
    Matrix Biol; 2012 May; 31(4):234-45. PubMed ID: 22421594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perlecan, a candidate gene for the CAPB locus, regulates prostate cancer cell growth via the Sonic Hedgehog pathway.
    Datta MW; Hernandez AM; Schlicht MJ; Kahler AJ; DeGueme AM; Dhir R; Shah RB; Farach-Carson C; Barrett A; Datta S
    Mol Cancer; 2006 Mar; 5():9. PubMed ID: 16507112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablation of Perlecan Domain 1 Heparan Sulfate Reduces Progressive Cartilage Degradation, Synovitis, and Osteophyte Size in a Preclinical Model of Posttraumatic Osteoarthritis.
    Shu CC; Jackson MT; Smith MM; Smith SM; Penm S; Lord MS; Whitelock JM; Little CB; Melrose J
    Arthritis Rheumatol; 2016 Apr; 68(4):868-79. PubMed ID: 26636652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7).
    Yu WH; Woessner JF
    J Biol Chem; 2000 Feb; 275(6):4183-91. PubMed ID: 10660581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SULF1 suppresses Wnt3A-driven growth of bone metastatic prostate cancer in perlecan-modified 3D cancer-stroma-macrophage triculture models.
    Brasil da Costa FH; Lewis MS; Truong A; Carson DD; Farach-Carson MC
    PLoS One; 2020; 15(5):e0230354. PubMed ID: 32413029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between prostate cancer cells and prostate fibroblasts promotes accumulation and proteolytic processing of basement membrane proteins.
    Ojalill M; Virtanen N; Rappu P; Siljamäki E; Taimen P; Heino J
    Prostate; 2020 Jun; 80(9):715-726. PubMed ID: 32364250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two different sources of Perlecan cooperate for its function in the basement membrane of the Drosophila wing imaginal disc.
    Bonche R; Chessel A; Boisivon S; Smolen P; Thérond P; Pizette S
    Dev Dyn; 2021 Apr; 250(4):542-561. PubMed ID: 33269518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
    Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
    J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of collagens and perlecan in microvascular stability: exploring the mechanism of capillary vessel damage by snake venom metalloproteinases.
    Escalante T; Ortiz N; Rucavado A; Sanchez EF; Richardson M; Fox JW; Gutiérrez JM
    PLoS One; 2011; 6(12):e28017. PubMed ID: 22174764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases.
    Whitelock JM; Murdoch AD; Iozzo RV; Underwood PA
    J Biol Chem; 1996 Apr; 271(17):10079-86. PubMed ID: 8626565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the heparan sulfate proteoglycan perlecan on human disease and health.
    Arikawa-Hirasawa E
    Am J Physiol Cell Physiol; 2022 Jun; 322(6):C1117-C1122. PubMed ID: 35417267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perlecan, a modular instructive proteoglycan with diverse functional properties.
    Melrose J
    Int J Biochem Cell Biol; 2020 Nov; 128():105849. PubMed ID: 32947020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparan sulfate accumulation and perlecan/HSPG2 up-regulation in tumour tissue predict low relapse-free survival for patients with glioblastoma.
    Kazanskaya GM; Tsidulko AY; Volkov AM; Kiselev RS; Suhovskih AV; Kobozev VV; Gaytan AS; Aidagulova SV; Krivoshapkin AL; Grigorieva EV
    Histochem Cell Biol; 2018 Mar; 149(3):235-244. PubMed ID: 29322326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.